Biogen Inc.
BIIB
$210.73
-$1.77-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 834.60M | 1.37B | 1.29B | 1.61B | 1.53B |
| Total Depreciation and Amortization | 842.90M | 801.10M | 779.90M | 763.70M | 744.30M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.50B | 1.27B | 1.19B | 1.00B | 702.90M |
| Change in Net Operating Assets | -300.50M | -852.00M | -1.06B | -920.60M | -861.00M |
| Cash from Operations | 2.88B | 2.59B | 2.20B | 2.45B | 2.12B |
| Capital Expenditure | -182.20M | -167.90M | -153.80M | -149.20M | -138.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -5.07B | -- | -- | 0.00 | -1.07B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -68.20M | -1.37B | -1.22B | -8.80M | -91.20M |
| Cash from Investing | -5.32B | -1.53B | -1.37B | -158.00M | -1.30B |
| Total Debt Issued | 2.40B | 1.73B | 1.73B | 1.73B | 1.73B |
| Total Debt Repaid | -1.38B | -2.03B | -2.03B | -1.75B | -1.75B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -38.00M | -25.80M | -5.00M | -140.10M | -16.80M |
| Cash from Financing | 985.00M | -322.70M | -301.90M | -157.00M | -33.40M |
| Foreign Exchange rate Adjustments | -22.10M | 49.60M | 101.90M | 25.00M | 70.60M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.47B | 784.40M | 633.50M | 2.16B | 849.90M |